GreenLine BDC, Inc. Rated “Strong Speculative Buy” by Harbinger Research with $1.75 Price Target

NEW YORK - Sept. 25, 2018 - PRLog -- GreenLine BDC, Inc. ("Company"), is positioned to be the first business development company primarily focused on the underserved U.S. cannabis-related financing and consulting market, announced today, that Harbinger Research has recently released a new research report on the Company.
GreenLine BDC, Inc. President and CEO, Ted Herman, stated, "We are extremely proud to announce the availability of an in-depth analysis of the Company's pre-IPO market focus and investment opportunity by a well respected, small-cap research firm like Harbinger Research.

The report carries a "Strong Speculative Buy" rating, and 12 month price target of $1.75 per share.
The U.S. cannabis market is large, rapidly growing and lacks a mature finance industry; 2017 sales were $9.2B; forecasts indicate a $47.3B market by 2027.

The report states: "Proprietors of both private and public cannabis companies, in some cases, cannot even access basic business banking services – much less institutional financing. GreenLine BDC intends to provide bridge loans, equity-line agreements and myriad consulting services, to assist well deserving private companies to become public in the U.S. via an IPO, and begin accessing capital more cost-effectively as a public company.

Brian Connell, CFA, Senior Research Analyst said, "This industry is in the midst of an extremely rapid growth cycle, and in our view the financing options currently available to companies in this space have not yet matured to a level commensurate with the current size and growth of the sector. This is a market vacuum that GreenLine BDC intends to fill."

Furthermore, the report states: "GreenLine BDC is for the time being a private company, although it plans to list first on the over the counter market in the U.S., followed at some point by an uplisting to either the NasdaqCM or the New York Stock Exchange (NYSE)."

Mr. Connell continued: "GreenLine BDC has (for this sector) an innovative and potentially very lucrative business model that helps both those cannabis companies that avail themselves of GreenLine's financial offerings, and those investors who become GreenLine BDC shareholders. We therefore rate the shares of GreenLine BDC a Strong Speculative Buy, and establish our 12-month price target at $1.75 per share." The research report is available here: GreenLine BDC, Inc. Legal Cannabis Sector Research Report prepared by Brian R. Connell, CFA for Harbinger Research. (https://greenlinebdc.com/research-report/)

Harbinger Research is an independent equity research firm focused on providing coverage to small-cap companies. Our mission is to help clients achieve fairer market valuations, expanded shareholder bases, improved liquidity and easier access to capital markets. We do this by providing insightful, in-depth research reports that are widely distributed and made available to both institutional and individual investors. To view our research reports, visit www.harbingerresearch.com.

About GreenLine BDC, Inc.
GreenLine BDC, Inc. is a pre-IPO business development company focused on the hyper-growth U.S. legal cannabis industry. GreenLine BDC's mission is to be the pre-eminent source of expertise, capital and market support for small-cap U.S. cannabis companies that are committed to an IPO within 6-12 months in order to raise the funds needed to finance organic growth and/or strategic acquisitions. For more information about the Company, visit www.greenlinebdc.com.

Company Contact:
Ted Herman, President and CEO
GreenLine BDC, Inc.
Telephone: 845-271-1732
E-Mail: ir@greenlinebdc.com

Contact
Mike Casson
***@greenlinebdc.com

Comments are closed.